Healthcare Webinars

Discover an informative webinar exploring patient-centered approaches shaping ophthalmology trials, uniting stakeholders for better treatments and outcomes. Clinical trials in ophthalmology require special considerations at every stage, including trial design, recruitment strategies, patient outreach and engagement, assessments and data collection and management of investigational products or devices. The key to success is putting the patients and their caregivers at the center when considering the overall approach to the trial. This panel session is fortunate to include the father of a child affected by Leber hereditary optic neuropathy (LHON) and will open with the perspective of a parent and active patient advocate. The speakers will address advances in trial design specific to rare/genetic diseases of the eye, with a focus on cell and gene therapy, the need to work collaboratively in this space to match advanced therapeutic trial design to the unique needs of investigating ocular diseases and how new perspectives on patient centricity is leading to the evolution of these trials. Join this webinar to gain insights into how sponsors, service providers, investigator sites, caregivers and patient advocacy groups can work together to accelerate the pace of bringing new treatments to these patients, for better outcomes and improved quality of life. Keywords: Clinical Trials, Rare Disease, Gene Therapy, Clinical Research, Patient-Centricity, CRO, Patient Recruitment, Cell Therapy, Eye Disease, Rare Disease Clinical Trials, Vision, Ophthalmology, Cell & Gene Therapies

This multiple-method study recently published in the European Journal of Pain provides credible explanations for the six most common diagnoses of non-traumatic knee pain. Additionally, it identified three key domains that may need to be addressed to reduce diagnostic uncertainty in adolescents suffering from pain complaints. Find out more about the study and its findings in this webinar and use the opportunity to ask questions. Here is the link: https://onlinelibrary.wiley.com/doi/full/10.1002/ejp.2210

International Pediatric Association invites you to join our webinar: “Survivorship in Childhood Cancer: Global Challenges”.

EHE Pillars in Practice: Diagnose, Treat, Prevent, Respond & Building Workforce Capacity in HIV Care and Treatment:  First Session: HIV Testing Training - focusing on innovative testing efforts to improve early diagnosisSpeaker:  Jorgette Theophilis Program Manager of HIV ServicesBrockton Neighborhood Health CenterAccreditation Statement:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of UMass Chan Medical School and New England AIDS Education and Training Center. The UMass Chan Medical School is accredited by the ACCME to provide continuing medical education for physicians.Credit Designation Statement: The University of Massachusetts Chan Medical School designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.Nurses: Under the auspices of the New England AIDS Education & Training Center, This offering meets the requirements for a maximum of 1.2 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Join this webinar to learn about the latest innovations in hand reconstructive surgery. The speakers will discuss topics such as upper limb reconstruction using the Profunda femoris artery perforator flap and 3D printing implant for Trapeziometacarpal arthritis.

The seminar focuses on the substantial and persistent racial and ethnic disparities in health in the USA, which affect children's health throughout their lives. Authors of The Lancet Child & Adolescent Health series will discuss how these inequities affect the quality of paediatric care in the USA.Speakers: Dr. Tiffani Johnson, Esther Lau, Dr. Natalie Slopen, Dr. Monique Jindal, Dr. Elizabeth Barnert, Dr. Nia Heard-Garris, and Dr. Nathan Chomilo.

The National ALS Registry is a multi-faceted research platform. Launched in 2010, the Registry evaluates the public health burden of ALS by determining who has ALS in the United States as well as investigating the causes and risk factors for this disease. The Registry also connects persons with ALS with clinical trials and epidemiological studies, funds research domestically and globally, and has a biorepository (i.e., National ALS Biorepository) where persons with ALS can donate their blood and saliva for research. This webinar will inform and educate persons with ALS and caregivers the importance of joining and being counted. Persons with ALS are the heart of the National ALS Registry and their data allows researchers to gain insight and advance research on genetics, biomarkers, and environmental exposures. With your help, we can potentially determine what causes and implement prevention measures in the future.

Parents and caregivers are uniquely positioned to make a profound impact on their child's development by acting as intervention agents. This webinar will focus on parent-led interventions for promoting social and communication skills with young children with autism. The activities shared can be incorporated into everyday routines and play that parents and caregivers can begin now!

Discover an informative webinar on checkpoint inhibitors in cancer immunotherapy, exploring immune checkpoint inhibitors (ICIs), FDA-approved therapies, combination treatments and strategies to predict patient responses in cancer treatment. Since their initial approval in 2011 for metastatic melanoma, ICIs have changed the treatment paradigm in oncology. To date, eight ICIs and 35 ICI-based combination immunotherapies have been approved by The FDA across diverse tumor types. First-line programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors have become increasingly common for the treatment of metastatic cancer, with significant survival benefits. Still, while a subset of patients exhibit deep, durable responses to these therapeutics, the majority do not respond to single-agent ICIs and many experience immune-related adverse events. To improve the efficacy and safety of ICIs and advance the understanding of the molecular pathways that cause cancer resistance, it is crucial to find new, effective and tolerable combination treatments. In this webinar, the featured speakers will explore the latest advancements in ICI and discuss strategies for expanding the use of these novel therapeutics. Join this webinar to discover insights shaping cancer treatment and learn about the impact of ICIs, patient responses and the future of ICI therapies.

BAJIS webinar seriesDate & Time Jan 24, 2024 06:00 PM in Universal Time UTCDescriptionSession 1: Prosthetic Joint InfectionSwitch Time ZoneOKCancelBAJIS Webinar Registration - 24th January 2024, 6pm GMT